FDA Approves Pfizer's Pneumococcal Vaccine for Adults Over 50

- 0 0
894   12 tahun lalu
karmastock | 0 Pelanggan
894   12 tahun lalu
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Pfizer Inc - PFE - reported that the FDA has granted approval of the Company’s pneumococcal conjugate vaccine Prevnar 13 for the Prevention of Pneumococcal Pneumonia and Invasive Disease in Adults 50 Years and Older.

KOMENTAR

0